4//SEC Filing
OncBioMune Pharmaceuticals, Inc 4
Accession 0001493152-16-007167
$THERCIK 0001362703operating
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:16 PM ET
Size
6.6 KB
Accession
0001493152-16-007167
Insider Transaction Report
Form 4
HEAD JONATHAN FREDERICK
DirectorChief Executive Officer
Transactions
- Award
Common stock
2015-09-02+17,951,078→ 17,951,078 total - Sale
Common stock
2015-09-02$0.00/sh−1,025,000$1,025→ 16,926,078 total
Footnotes (1)
- [F1]Received in exchange for all of the reporting person's shares of OncBioMune, Inc. ("ONC") common stock in connection with the exchange pursuant to that certain exchange agreement dated as of June 22, 2015, as amended, among the registrant, ONC and the ONC shareholders.
Documents
Issuer
OncBioMune Pharmaceuticals, Inc
CIK 0001362703
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001362703
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:16 PM ET
- Size
- 6.6 KB